Study of i-ED COILs for chronic subdural hematoma treatment
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests a special coil device called i-ED COILs, used alone or with standard surgery, to treat chronic subdural hematoma (a slow-growing blood collection on the brain). It may help patients who need an intervention for their condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a chronic subdural hematoma that is causing symptoms and needs treatment
- Before this condition, you were able to do daily activities without major help (score of 0 to 3 on a scale called mRS)
- You do not have an acute (sudden) subdural hematoma
- You do not have another type of mass in your brain besides the subdural hematoma
- If female, you are not pregnant or breastfeeding
- You are expected to live long enough to complete the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry for people with a subdural hematoma (a blood collection on the surface of the brain) who are planning to have a procedure to block one of the arteries in the scalp. The registry will track how these patients do over time.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial compares two ways to treat a chronic subdural hematoma (a long-lasting bleed between the brain and its covering): blocking a specific artery versus standard surgery to remove the blood. It may help you and your care team choose the safer and more effective option for your situation.
This trial tests a new minimally invasive procedure using PHIL, a liquid embolic agent, to treat chronic subdural hematoma—bleeding on the brain that develops slowly over weeks. Instead of surgery, doctors inject PHIL into the middle meningeal artery to reduce bleeding and relieve symptoms like headaches, dizziness, or weakness.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.